BBOT

BridgeBio Oncology
BBOT

Overview Fund Trends Analyst Outlook Journalist POV

29 hedge funds and large institutions have $167M invested in BridgeBio Oncology in 2024 Q1 according to their latest regulatory filings, with 29 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
29
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$30.3M
2
+$15.6M
3
+$14.6M
4
Citadel Advisors
Citadel Advisors
Florida
+$13.8M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$11.7M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$30.3M
2
$15.6M
3
$14.6M
4
$13.8M
5
$11.7M
6
$11.5M
7
$7.33M
8
$6.21M
9
$5.2M
10
$5.2M
11
$5.2M
12
$5.2M
13
$4.94M
14
$4.2M
15
$4.14M
16
$3.12M
17
$3.1M
18
$2.59M
19
$2.59M
20
$2.09M
21
$2.08M
22
$1.97M
23
$1.11M
24
$1.03M
25
$955K
1
2